Related Experiment Video
Updated: Oct 2, 2026
High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
Published on: July 17, 2014
Partial characterization of a low molecular weight phagocytosis inhibitory factor obtained from human erythrocyte
L Baranyi1, K Baranji, T Yoshida
1Department of Molecular Biology, Nagoya City University School of Medicine, Japan.
Abstract:
Phagocytosis Inhibitory Factor (PIF), a small (< 3000 D) molecule, was partially purified from human red blood cell membranes. This factor inhibits latex phagocytosis by monocytic cells. PIF is not toxic under the experimental conditions employed and the phagocytosis inhibitory activity is reversible since removal of this factor restores the phagocytic capability of cells. The phagocytic activity of murine macrophages was not affected by PIF.
Insights
Phagocytosis Inhibitory Factor (PIF) from human red blood cells was purified. This molecule selectively inhibits phagocytosis in monocytic cells but not in murine macrophages, with reversible effects.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Phagocytosis is a critical cellular process for immune defense and homeostasis.
- Factors influencing phagocytic activity are key to understanding immune regulation.
- Human red blood cell membranes are a source of bioactive molecules.
Purpose of the Study:
- To partially purify and characterize a novel Phagocytosis Inhibitory Factor (PIF).
- To investigate the effect of PIF on phagocytosis by monocytic cells.
- To determine the specificity and reversibility of PIF's inhibitory action.
Main Methods:
- Partial purification of PIF from human red blood cell membranes.
- Assay of latex bead phagocytosis by monocytic cells in the presence of PIF.
- Testing PIF's effect on murine macrophage phagocytic activity.
- Assessment of PIF toxicity and reversibility of its inhibitory action.
Main Results:
- A small molecule (< 3000 D), identified as PIF, was isolated.
- PIF significantly inhibited latex phagocytosis by human monocytic cells.
- PIF demonstrated no toxicity to cells under experimental conditions.
- The inhibitory effect of PIF on phagocytosis was reversible upon its removal.
- Murine macrophages' phagocytic activity remained unaffected by PIF.
Conclusions:
- PIF is a novel, non-toxic, and reversible inhibitor of phagocytosis in human monocytic cells.
- PIF exhibits cell-specific inhibitory activity, not affecting murine macrophages.
- PIF represents a potential target for modulating immune responses involving monocytic phagocytes.
